Printer Friendly

STERLING WINTHROP SCIENCE FELLOWSHIP PROGRAM UNVEILED AT DEDICATION OF PHARMACEUTICAL RESEARCH DIVISION R&D CENTER IN UPPER PROVIDENCE TOWNSHIP

 UPPER PROVIDENCE, Pa., May 10 /PRNewswire/ -- The Sterling Winthrop Pharmaceuticals Research Division (SWPRD) today unveiled the Sterling Winthrop Science Fellowship program as part of the dedication celebration for the division's new U.S. pharmaceutical R&D center, here. The Fellowship was jointly announced by company officials and administrators of the Spring-Ford High School, where the Fellowship will be implemented.
 Under terms of the Fellowship, six teachers will have the opportunity to take a paid one-week internship in the Sterling Winthrop laboratories to gain insight into modern science application and careers, as well as brainstorm ideas with Sterling Winthrop researchers for an enhanced science curriculum.
 "This Science Fellowship will continue a Sterling Winthrop tradition of announcing novel science education programs at milestones in our settling into the Upper Providence Township community," said Eugene H. Cordes, Ph.D., president of the Sterling Winthrop Pharmaceuticals Research Division, at the ceremony today. "We are delighted to add this program for area teachers to our roster of science education and community programs in this region."
 The Science Fellowship complements Sterling Winthrop community programs already in place, including Science in the Schools, where students learn directly from Sterling Winthrop researchers through hands-on experiments; the Sterling Winthrop Explorers program with the Boy Scouts of America; Science Screen Report video series sponsorship; Science-by-Mail, a national mentorship program for grade school students; and the judging of science fairs and other programs that Sterling Winthrop researchers participate in at Spring-Ford and five other school districts in the area.
 "We are delighted to continue our partnership with Sterling Winthrop and eager to begin the Fellowship program this year," said Dr. Edwin Coyle, superintendent of the Spring-Ford School District, at the dedication ceremony.
 Sterling Winthrop Fellowship participants will join researchers, both biologists and chemists, in the Sterling Winthrop laboratories for a one-week program that includes mentoring in the basic sciences of biology, chemistry and mathematics, and the applied sciences, such as natural products chemistry, analytical and synthetic chemistry, pharmacokinetics, formulation sciences, molecular biology, biostatistic and computer technology.
 Fellowship teachers will provide feedback on the program as follow- up to their internship. Program development will be co-administered by Sterling Winthrop and the Spring-Ford School District. Each teacher will be awarded a $500 stipend for the internship, with $250 each being contributed by the district and Sterling Winthrop.
 The Fellowship program was developed jointly by school district officials and teachers and the members of the Sterling Winthrop Education Committee, explained committee chairman Tom Oswald, an Oncology Project Manager at SWPRD. "This program allows Sterling Winthrop to share our resources and technology with teachers in a special way so that they can gain insight into new advances in sciences and careers in science that they can pass on to their students -- many of whom are children of Sterling Winthrop people," Oswald said.
 The Sterling Winthrop Science Fellowship complements Sterling Winthrop's growing corporate emphasis on secondary education, including corporate-based efforts that focus on strengthening and improving educational systems in Sterling Winthrop communities around the world.
 Sterling Winthrop's pharmaceutical research and development expenditures, as a result of the company's alliance with French-based Elf Sanofi, rank among the top 12 in the industry at more than one-half billion dollars annually. In December of 1992, Sterling Winthrop described a robust pipeline of products that includes innovative diagnostic imaging agents and distinctive treatments for brain and other cancers, heart disease, osteoporosis and prostate disorders, among others.
 Sterling Winthrop Inc. is a global developer, manufacturer and marketer of pharmaceuticals and consumer health products. With headquarters in New York City, Sterling Winthrop is a subsidiary of Eastman Kodak Company (NYSE: EK).
 -0- 5/10/93
 /CONTACT: Carol J. Perlman, 212-907-2724, or Terry G. Kelley, 212-907-3009, both of Sterling Winthrop/


CO: Sterling Winthrop ST: Pennsylvania IN: MTC SU:

LR-TS -- NY056 -- 6593 05/10/93 15:15 EDT
COPYRIGHT 1993 PR Newswire Association LLC
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 1993 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:PR Newswire
Date:May 10, 1993
Words:634
Previous Article:STERLING WINTHROP DEDICATES PHARMACEUTICALS RESEARCH AND DEVELOPMENT CENTER IN UPPER PROVIDENCE TOWNSHIP, PA.
Next Article:STATE SUPREME COURT AFFIRMS LOTTERY CONTRACT AWARD
Topics:


Related Articles
DR. JONAS SALK, ELIE WIESEL HIGHLIGHT DEDICATION OF RPR'S RESEARCH AND CORPORATE HEADQUARTERS; AIDS BENEFIT FEATURES BACHARACH, WARWICK, FLACK
SALK, WIESEL HIGHLIGHT DEDICATION OF HEADQUARTERS FOR RHONE-POULENC RORER; BACHARACH, WARWICK, FLACK AND BOOSLER HEADLINE AIDS BENEFIT
CONTRAST MEDIA RESEARCH ALLIANCE FORMED BY STERLING WINTHROP AND STANFORD UNIVERSITY
CARDIOVASCULAR HEALTHCARE AWARD OF EXCELLENCE TO EARL K. SHIREY, M.D. OF CLEVELAND CLINIC FOUNDATION
STERLING WINTHROP ANNOUNCES MAY 10 DEDICATION OF PHARMACEUTICAL R&D CENTER IN UPPER PROVIDENCE TOWNSHIP, PA.; PAULING AND KELLEY TO SPEAK
STERLING WINTHROP DEDICATES PHARMACEUTICALS RESEARCH AND DEVELOPMENT CENTER IN UPPER PROVIDENCE TOWNSHIP, PA.
STERLING WINTHROP AND ELF SANOFI ANNOUNCE JOINT DEVELOPMENT AND COMMERCIALIZATION OF TWO NEW AGENTS WITH BRISTOL-MYERS SQUIBB
STERLING WINTHROP NAMES SHOFF V.P., OPERATIONS, PHARMACEUTICALS GROUP; PETERS SUCCEEDS SHOFF AS PRESIDENT, SANOFFI WINTHROP USA
CLOSING COMPLETED, SANOFI NAMES MANAGEMENT TEAM FOR PHARMACEUTICAL DIVISION
SMITHKLINE BEECHAM ACQUIRES PHARMACEUTICAL R&D FACILITY FROM EASTMAN KODAK

Terms of use | Copyright © 2017 Farlex, Inc. | Feedback | For webmasters